Preemptive analgesia with controlled-release oxycodone is successful in prevention of post-inguinal herniorrhaphy pain
| Autor: | Gregory Fleishman, Juan Carlos Cozacov, Igor Dashkovsky, Semion Asaulenco |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
medicine.medical_specialty
Visual analogue scale business.industry Group ii Placebo Controlled release law.invention Surgery Medical–Surgical Nursing Anesthesiology and Pain Medicine Randomized controlled trial law Anesthesia Inguinal herniorrhaphy medicine Antipyretic business Oxycodone medicine.drug |
| Zdroj: | Ambulatory Surgery. 11:11-13 |
| ISSN: | 0966-6532 |
| DOI: | 10.1016/j.ambsur.2004.04.001 |
| Popis: | In a double-blind randomized study, controlled-release (CR) oxycodone (OxyContin ®) administration was assessed against placebo to ascertain the extent of postinguinal herniorrhaphy pain control. Patients received a single dose of CR oxycodone (40 mg orally) or placebo 40 min before surgery. When post-surgical pain was first reported, a visual analogue scale (VAS) was used to assess pain score. Postoperative pain-free time, dolestin (opiod) and dipyrone (antipyretic) consumption were assessed 24 h after the surgery. Postoperative pain-free time in the CR oxycodone group (Group I) was 655±548 min versus 112±71.5 min in the placebo group (Group II) (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|